Clinical trial
Sitagliptin in the Elderly
NCT00451113 · University of British Columbia, Other · Completed
Key facts
| NCT number | NCT00451113 |
|---|---|
| Title | Sitagliptin in the Elderly |
| Official title | Sitagliptin in the Elderly |
| Lead sponsor | University of British Columbia, Other |
| Collaborators | Merck Frosst Canada Ltd. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | Sitagliptin 100 mg |
| Enrollment | 12 |
| Start date | Nov 1, 2006 |
| Primary completion | Nov 1, 2012 |
| Completion | Nov 1, 2012 |
| First posted | Mar 23, 2007 |
| Last update posted | Jan 18, 2018 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: